Home/Catapult Therapeutics/Dominik Höchli
DH

Dominik Höchli

Co-Managing Director

Catapult Therapeutics

Therapeutic Areas

Catapult Therapeutics Pipeline

DrugIndicationPhase
CAP-100Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Phase 1